Posts in category

In Depth


Every King has his Achilles heel, writes Mouhamad Zoghbi… economists and health professionals are degrees apart This king stood with a confidence that shook the pharmacy nation. He didn’t stutter …

Debbie Rigby presents her weekly round-up of the latest clinical research relevant to community pharmacy Multicenter Observational Study of Incretin-based Drugs and Heart Failure A large cohort study of nearly …

AJP is celebrating a special birthday Australia’s oldest journal of record – the Australian Journal of Pharmacy – is turning 130 this year. The first edition of the then Australasian …

Collaboration and communication with patients is key to helping legitimate pain patients, with real-time monitoring useful for catching misusers of codeine only. Most people who become dependent on over-the-counter codeine …

Ben Basger presents 10 points to consider on Parkinson’s Disease… Parkinson’s disease is much more than a movement disorder! Dopamine loss in the substantia nigra, which serves to modify motor …

Debbie Rigby presents the latest research relevant to pharmacists Hydrolysed formula and risk of allergic or autoimmune disease A systematic review and meta-analysis of 37 trials involving over 19,000 participants …

Pharmacies will never be able to get ahead without a real point of difference, writes John Cao One lesson that I have taken away from watching the many episodes of …

During the roller coaster ride that’s becoming a parent, new mums and dads may need more help than they’re keen to admit, writes Karalyn Huxhagen Becoming a new parent is …

Debbie Rigby covers the latest research relevant to pharmacists Diagnosis and Management of Diabetes The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to …

Pharmacists can help identify patients at risk of serious injury from falls, writes Ben Basger Falls may result in serious injury. For example, 12 months after a hip fracture in …

Debbie Rigby covers the latest research relevant to pharmacists Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder This study represents the first evaluation of the relative benefits of onabotulinumtoxinA …

Pharmacy no longer need be a ‘discount’ or ‘service’ model. The new ‘optimal pharmacy’ model optimises profits and health outcomes, writes Mouhamad Zoghbi The general consensus between today’s pharmacy leaders …